Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salofalk in colonic diverticulosis
NCT01627262Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- May 2002
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Salcrozine in Colonic Diverticulosis (CD), sponsored by Dr. Falk Pharma GmbH. Started May 2002; status: completed.
02
Drugs
Salcrozine
03
Conditions
Colonic Diverticulosis (CD)
Beyond the preview
Go deeper on NCT01627262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627262.